Healthcare News

Daix (France), New York City (New York, Etats-Unis), le 8 avril 2026 – Inventiva (Euronext Paris et Nasdaq : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le...

Daix (France), New York City (New York, United States), April 8, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA) (the “Company”), a clinical-stage biopharmaceutical company focused on the...

AX-0810 clinical target engagement data in healthy volunteers on track for this quarter; biliary atresia selected as initial Phase 2 indicationAdditional programs advancing toward the clinic,...

ASSEMBLÉE GÉNÉRALE MIXTE DU 29 AVRIL 2026 MODALITÉS DE MISE À DISPOSITION OU DE CONSULTATION DES DOCUMENTS PRÉPARATOIRES Les actionnaires de la Société sont invités à participer à l’assemblée...

  COMBINED GENERAL MEETING OF APRIL 29, 2026 AVAILABILITY OF PREPARATORY DOCUMENTS The Company’s shareholders are invited to attend the Combined General Meeting to be held on Wednesday April 29,...

 - Ordinary shares expected to commence trading on Nasdaq on April 20, 2026 following exchange of all American Depositary Shares (ADSs)  - ADS holders will receive one ordinary share listed on Nasdaq...

A single-dose of Trogenix’s proprietary Synthetic Super-Enhancers achieved complete tumour elimination in 83% of treated cases with no toxicity over 11 months and no tumour recurrence in a brain...

23andMe Research Institute Study, Published in Nature, Identifies Genetic Predictors for GLP-1 Weight Loss Efficacy and Side Effects

Langenfeld, Germany, April 08, 2026 (GLOBE NEWSWIRE) -- Booking Health, a global medical travel provider, announced today the release of its 2026 report on advanced head and neck cancer treatment...

Spider silk’s extraordinary combination of strength, elasticity, toughness, biocompatible, biodegradable, and low weight, properties that outperform Kevlar